SCHEMBL2637265

SCHEMBL2637265

[2H-].[2H-].[2H-].[Al+3].[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6267385 0.82 — —
SCHEMBL158768 0.82 — —
Water SCHEMBL4324053 0.67 — —
Fluoride Ion SCHEMBL1449912 0.67 — —
Bromide SCHEMBL11351766 0.67 — —
Lithium Ion SCHEMBL168217 0.67 — —
SCHEMBL340727 0.67 — —
SCHEMBL1003257 0.67 — —
SCHEMBL3120698 0.67 — —
SCHEMBL20969 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212266-A1 DEUTERATION OF MARKING MATERIALS BASF SE (DE) 2010-08-04 — — EP claimed
WO-2009065789-A1 DEUTERATION OF MARKING MATERIALS BASF SE (DE) 2009-05-28 — — WO claimed
EP-1266384-A4 COLD NUCLEAR FUSION UNDER NON-EQUILIBRIUM CONDITIONS PARTICLE PHYSIC RES COMPANY LL (US) 2003-07-23 — — EP claimed
US-20030112916-A1 Cold nuclear fusion under non-equilibrium conditions PARTICLE PHYSICS RESEARCH COMPANY. L.L.C. 2003-06-19 — — US claimed
EP-1266384-A2 COLD NUCLEAR FUSION UNDER NON-EQUILIBRIUM CONDITIONS Particle Physic Research Company, LLC (US) 2002-12-18 — — EP claimed
WO-2001063979-A2 COLD NUCLEAR FUSION UNDER NON-EQUILIBRIUM CONDITIONS PARTICLE PHYSICS RESEARCH COMPANY, L.L.C. (US) 2001-08-30 — — WO claimed
EP-3515919-A1 N3-CYCLICALLY SUBSTITUTED THIENOURACILES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2019-07-31 — — EP disclosed
EP-3274352-B1 HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR Bayer Pharma AG (DE) 2019-01-02 — — EP disclosed
WO-2018054846-A1 N3-CYCLICALLY SUBSTITUTED THIENOURACILES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-03-29 — — WO disclosed
EP-3274352-A1 HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR Bayer Pharma Aktiengesellschaft (DE) 2018-01-31 — — EP disclosed
EP-2237285-B1 Apparatus and method for determining the power level of a nuclear reactor GE HITACHI NUCLEAR ENERGY AMERICAS LLC (US) 2017-11-22 — — EP disclosed
EP-2914596-B1 HYDROXY SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE CARBOXAMIDES AND THEIR USE AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE Bayer Pharma AG (DE) 2017-06-21 — — EP disclosed
EP-2734488-B1 PRODUCTION OF OPTICALLY PURE PROPANE-1,2-DIOL THYSSENKRUPP IND SOLUTIONS AG (DE) 2016-10-05 — — EP disclosed
WO-2001074820-A1 NOVEL DERIVATIVES AND ANALOGUES OF GALANTHAMIN SANOCHEMIA PHARMAZEUTIKA AKTIENGESELLSCHAFT (AT) 2001-10-11 — — WO disclosed
WO-2001063979-A2 COLD NUCLEAR FUSION UNDER NON-EQUILIBRIUM CONDITIONS PARTICLE PHYSICS RESEARCH COMPANY, L.L.C. (US) 2001-08-30 — — WO disclosed
EP-0453262-B1 Chlorinated ethylene-alpha-olefin copolymer rubber and composition thereof MITSUI PETROCHEMICAL IND (JP) 1995-09-06 — — EP disclosed
US-5237010-A High vulcanization speed and improved heat resistance MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1993-08-17 — — US disclosed
US-5206305-A High speed vulcanization; heat resistance MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1993-04-27 — — US disclosed
EP-0453262-A2 Chlorinated ethylene-alpha-olefin copolymer rubber and composition thereof MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-10-23 — — EP disclosed
US-4935437-A (Substituted aralkyl) heterocyclic compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-19 — — US disclosed
Send feedback